INSIGHTS ON DRUG DEVELOPMENT
-
![api-clinicial-tech-gettyimages-2149749988-170667a]( "Biocatalysis 101: Faster, Greener API Manufacturing")
Biocatalysis 101: Faster, Greener API ManufacturingView how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.
-
![EHR Checklist, secure digital workflow, medical records, patient date-GettyImages-2234691940]( "CMC (Chemistry, Manufacturing and Controls) Management")
CMC (Chemistry, Manufacturing and Controls) ManagementEliminate regulatory risks caused by fragmented data. Learn how a continuous data thread from bench to batch streamlines tech transfer and accelerates filing timelines.
-
![getty-1311598658-data-analytics]( "Enabling Quality By Design")
Enabling Quality By DesignOutdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.
-
![GettyImages-1334095553-vial-computer-data-pipette-scientist-lab]( "Formulation And Analytical Tour")
Formulation And Analytical TourTake a brief tour of Nanoform’s advanced nanoformulation, nanoanalytical, and best-in-class capabilities.
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges2/3/2025
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
Manufacturing CAR T Cell Therapies: Challenges, Insights And Solutions6/16/2025
Manufacturing patient-specific cell therapies is a complex, multi-step process. Addressing key hurdles in production time, scalability, and cost is crucial to making these vital treatments more accessible.
-
A Scientist's Perspective: Minimizing Hands-On Time In Molecular Assays3/26/2026
Autonomous digital PCR provides absolute quantification in complex matrices. Achieve five-color multiplexing and streamlined data collection without standard curves to accelerate synthetic biology.
-
Quicker Development Using Cell Line Integration, End-To-End Support6/19/2025
Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.
-
How Do You Start Process Transfer For A New Client?7/23/2026
Anmaris Torres, Process Engineering Team Leader, on why a process transfer starts with a conversation across departments to figure out how to cut cycle time before commercial production begins.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-1426756188-scientists-in-lab-with-computer-analyzing]( "Improve The Performance Of Your Biologic Formulations")
Advanced nanotechnology improves biologics with higher drug loads, better stability, new delivery routes, and enhanced performance in injectables, inhalation, and long‑acting therapies.
-
![Brochure Feature]( "Microcalorimetry: ITC & DSC")
Discover three solutions that provide the performance, reliability, and ease-of-use required for the most demanding applications in drug discovery, protein-protein interactions, structure-function characterization, and more.
-
![GettyImages-1293772880-Lab-Science-Research-Scientist-Discovery-Development]( "Empowering Biologics Development With HRMS Services")
Examine ways to accelerate biologic development with high-resolution mass spectrometry services that deliver precise, reliable data from discovery through commercial release.
-
![Scientist Using Tablet In Lab GettyImages-1354172577]( "PBPK Predictive Modeling Services")
Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.
-
![iStock-1214764688-scientist-lab-analyze-research]( "Analytical And Testing Services")
As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating physico-chemical properties of primary packaging materials and components and studying the interactions between container closure system and drugs. Stevanato Group relies on a multi-disciplinary team of highly skilled professionals, including, scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience covers a range of specialized areas including container closure systems and drug-delivery devices.
